OCTRI KL2 Opportunity
The letter of intent deadline for the 2013 OCTRI KL2 opportunity has passed. Applicants have been notified if they have been invited to submit a full application. The next funding opportunity for the OCTRI KL2 will be in early 2014 for appointments beginning in July 2014.
This opportunity is designed to support the research training and career development of investigators to conduct interdisciplinary research with scientists from diverse disciplines for a maximum of two years. All research proposed for this program must involve either clinical or translational research defined as research with human subjects or populations or with direct application to human health. At the end of this two year KL2 appointment, the scholar is expected to have received an independent career development award, such as a K award from NIH or independent funding such as a R01.
- KL2 Scholar Support
- Selection Criteria
- Key Dates
- Letter of Intent Submission
- Complete RFA
OCTRI KL2 Scholar Support
- Up to 75% of the scholar's salary annually (not to exceed a cap of $75,000 plus OPE) for 2 years. It is expected that the scholar's department will provide salary support for scholars with higher salaries.
- A commitment of 75% FTE to research and career development for 2 years.*
- $25,000 per year in research and travel funds.
- Tuition-waiver for courses in the Human Investigations Program, including the Master of Clinical Research or Certificate in Human Investigation tracks. Courses or conferences outside of this program should be paid from research funds.
- Participation in OCTRI-supported networking and mentoring activities such as offered by the OCTRI Scholars Program.
- Access to a multidisciplinary pool of highly qualified mentors through the OCTRI Design Studio, who will guide research projects and career development.
- Priority support from OCTRI cores and services.
Applicants must meet all the following requirements for the OCTRI KL2 award:
- U.S. Citizen or Permanent Resident. Individuals with temporary or student visas are not eligible
- Hold a clinical doctorate (e.g. MD/DO, DMD/DDS, DNS, PharmD, ND, OD, DC) or a research doctorate (PhD) and have a current or pending primary faculty appointment at OHSU as an Assistant Professor level or equivalent. Clinicians must have completed specialty or subspecialty training by the time of the award.
- No prior funding as principal investigator on an NIH research grant, including an R01 or any K series grant; or PI of a subproject of a program project grant (P01), center grant (P50, P60, U54); or other equivalent grant awards. Candidates are eligible if they have been supported by an NRSA grant (F or T) or an NIH small grant (R03 or R21).
- KL2 applicants may not simultaneously submit or have pending an application for any other PHS mentored career development award (e.g. K07, K08, K22, or K23) that duplicates the provisions of the KL2 program.
Selection CriteriaA KL2 selection committee will follow the model of the NIH peer review process for K awards. Selection criteria will focus on the strengths and potential of the candidate to become a leading multidisciplinary investigator judged in five major domains:
- Potential of the Applicant: potential to conduct multidisciplinary research judging by research expertise and prior training; publications; prior participation in research.
- Research Plan: Scientific value, potential clinical importance, and feasibility of the written multidisciplinary research plan
- Training Plan: Quality, appropriateness, and composition of the multidisciplinary team of the proposed mentors; plan to gain didactic and other training at OHSU or elsewhere
- Mentors: Tangible commitment and resources provided by the home department, including protected research time, and suitability of the available clinical and laboratory infrastructure and multidisciplinary team
- Career Potential: Global assessment of the likelihood that the candidate will develop a career as an outstanding independent investigator and conduct research that will have an important impact on health. Individuals from underrepresented groups in research (women, ethnic minorities, and the disabled) are encouraged to apply. Special consideration will be given to individuals in disciplines traditionally under-represented in clinical and translational research.
|RFA released||Friday, November 20, 2013|
|Letter of Intent deadline
||Monday, January 14, 2013|
|Notification of full application invitees
||Wednesday, January 30, 2013|
|Full application deadline
||Monday, March 4, 2013|
|Notification of invitation to present
||Monday, April 8, 2013|
|Presentation to selection committee
||Monday, April 22, 2013, afternoon|
|Earliest funding start date
||July 1, 2013|
Letter of Intent Submission
The letter of intent is required of all applicants and will be used to determine which applicants will be invited to submit a full application. The letter of intent is limited to a maximum of one page. Applicants must follow NIH guidelines with 11-point Arial font and one-half inch margins.
- A current biosketch in NIH format or curriculum vitae, if the biosketch is not available, should be submitted with the letter of intent.
- Submit both documents via online application. You will be asked to complete some demographic information before uploading documents.
Letters of intent must address the following areas and questions:
- Research question to be investigated
- Preliminary data, if any
- Brief summary of the scientific plan
- Brief details of educational and training plan
- Proposed mentor team and primary mentor
The complete RFA includes additional details about the submission process, eligibility, and email@example.com) or Cynthia Morris (firstname.lastname@example.org).